AU2001274381A1 - A bioavailable dosage form of loratadine - Google Patents

A bioavailable dosage form of loratadine

Info

Publication number
AU2001274381A1
AU2001274381A1 AU2001274381A AU7438101A AU2001274381A1 AU 2001274381 A1 AU2001274381 A1 AU 2001274381A1 AU 2001274381 A AU2001274381 A AU 2001274381A AU 7438101 A AU7438101 A AU 7438101A AU 2001274381 A1 AU2001274381 A1 AU 2001274381A1
Authority
AU
Australia
Prior art keywords
loratadine
dosage form
bioavailable dosage
bioavailable
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274381A
Inventor
Dinsheet Gupta
Pananchukunath Manoj Kumar
Rajiv Malik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11097068&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001274381(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2001274381A1 publication Critical patent/AU2001274381A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

A bioavailable oral dosage form of loratadine of specific particle size and surface area.
AU2001274381A 2000-07-17 2001-06-21 A bioavailable dosage form of loratadine Abandoned AU2001274381A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN651DE2000 IN192160B (en) 2000-07-17 2000-07-17
IN651/DEL/2000 2000-07-17
PCT/IB2001/001098 WO2002005816A1 (en) 2000-07-17 2001-06-21 A bioavailable dosage form of loratadine

Publications (1)

Publication Number Publication Date
AU2001274381A1 true AU2001274381A1 (en) 2002-01-30

Family

ID=11097068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274381A Abandoned AU2001274381A1 (en) 2000-07-17 2001-06-21 A bioavailable dosage form of loratadine

Country Status (13)

Country Link
US (1) US20020035119A1 (en)
EP (1) EP1303276B1 (en)
AT (1) ATE278404T1 (en)
AU (1) AU2001274381A1 (en)
BR (1) BR0112597A (en)
DE (1) DE60106266T2 (en)
DK (1) DK1303276T3 (en)
ES (1) ES2230325T3 (en)
HK (1) HK1055256A1 (en)
IN (1) IN192160B (en)
PT (1) PT1303276E (en)
WO (1) WO2002005816A1 (en)
ZA (1) ZA200300439B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9241997B2 (en) 2003-06-13 2016-01-26 Idh Holding Aps Treatment of symptoms associated with bacterial vaginosis
JP3881640B2 (en) * 2003-08-08 2007-02-14 塩野義製薬株式会社 Dry syrup containing loratadine
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
WO2006076097A2 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
CA2628716C (en) * 2005-11-10 2016-09-27 Alphapharm Pty Ltd Process to control particle size
US20100104636A1 (en) * 2006-12-21 2010-04-29 Panagiotis Keramidas Pharmaceutical Compound and Composition
EP2318350A4 (en) * 2008-07-25 2012-11-28 Alphapharm Pty Ltd ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 muM TO ABOUT 10 muM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980778A (en) * 1973-10-25 1976-09-14 The Upjohn Company Anti-inflammatory steroid
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IL131317A (en) * 1999-08-09 2006-08-01 Cts Chemical Ind Ltd Binder for pharmaceutical compositions

Also Published As

Publication number Publication date
EP1303276A1 (en) 2003-04-23
WO2002005816A1 (en) 2002-01-24
DE60106266T2 (en) 2006-02-23
DK1303276T3 (en) 2005-02-07
DE60106266D1 (en) 2004-11-11
PT1303276E (en) 2005-02-28
ES2230325T3 (en) 2005-05-01
ATE278404T1 (en) 2004-10-15
HK1055256A1 (en) 2004-01-02
ZA200300439B (en) 2004-02-10
US20020035119A1 (en) 2002-03-21
BR0112597A (en) 2003-08-12
EP1303276B1 (en) 2004-10-06
IN192160B (en) 2004-02-28

Similar Documents

Publication Publication Date Title
AU2002301259A1 (en) Simethicone solid oral dosage form
AUPQ899700A0 (en) Probiotic recolonisation therapy
IL136901A0 (en) Flash-melt oral dosage formulation
AU2001233529A1 (en) Probiotic therapy for newborns
AU3977099A (en) Controlled release oral dosage form
AU2001289521A1 (en) Biologically active oral preparation that can be site-specific released in colon
AUPQ676800A0 (en) Dental device
AU2001292297A1 (en) Mouthpiece for orthodontic treatment and device for orthodontic treatment using the mouthpiece
AU2001271583A1 (en) Absorbent article tablet
AU2001259693A1 (en) Oral devices
CA2388671A1 (en) Magnetic therapeutic mouth piece
AU2001292732A1 (en) Beta-lactam analogs and uses therefor
AU2001274381A1 (en) A bioavailable dosage form of loratadine
AU2001296622A1 (en) Oral devices
WO2003080056A3 (en) Fine particle size pioglitazone
AU2001290109A1 (en) Device for administering doses of particulate material
AU2001280830A1 (en) Paroxetine tablets and capsules
AU2002217444A1 (en) Air-driven generating device
AU2002212683A1 (en) Preventive or therapeutic medicines for hepatitis and/or hepatopathy
AU4449501A (en) Production and use of dissolved bioavailable selenium
AU2000261875A1 (en) Mouse pad
AU2001261320A1 (en) Improved light-generating and beam-establishing device
AU2002345385A1 (en) Compositions and preparation methods for bioavailable oral aceaceclofenac dosage forms
AU2002213034A1 (en) Devices and techniques for logical processing
AU2002228432A1 (en) Counting and feeding device for small article